viewPressure BioSciences, Inc.

Pressure BioSciences merger partner receives $3.5 million order for hand sanitizer product

The firm's merger partner, SkinScience, is the parent company of the Dr Denese skin care and anti-aging product lines

Pressure BioSciences, Inc. - Pressure BioSciences receives $3.5 million order for hand sanitizer product
The company went back to the lab and formulated a premium quality, dermatologically driven hand sanitizer

Pressure BioSciences Inc (OTCQB:PBIO) said its merger partner, SkinScience Labs, has received an initial $3.5 million order for its newly developed dermatological hand sanitizer product.

Pressure BioSciences agreed to acquire SkinScience in April and the merger is expected to close on by June 30.

READ: Pressure BioSciences eyeing around $2.4 million in 1Q 2021 as it sells its first manufacturing run of BaroShear K45 systems

SkinScience is the parent company of the Dr Denese skin care and anti-aging product lines, developed by Adrienne Denese, an industry leader in scientific skin care breakthrough technologies.

"Our goal has always been to develop and supply the highest quality of personal care products expected by our very loyal customer base. Over the past few months, shortages of hand sanitizers have been reported by stores all over the US. With SkinScience Labs' nearly two decades of experience in formulation, manufacturing, and distribution, and my expertise and training as a scientist and physician, it became clear that we could become an important new part of the solution. With particular focus on the adverse effects that the high alcohol content in typical hand sanitizers have on skin, we went back to the lab and formulated a premium quality, dermatologically driven hand sanitizer. We recently made the decision to release this very effective, premium product to the market,” Denese said in a statement.

Following the merger, Pressure BioSciences will change its name to Availa Bio and will be led by Jim Morrison, the former president of L'Oreal.

"Dr Adrienne Denese is an accomplished doctor, scientist, businesswoman, and skin care visionary. It therefore came as no surprise that she chose to expand her very popular cosmetics line with the addition of a premium quality hand sanitizer based on her own proprietary formulation. With the high quality and care that Adrienne famously builds into all of her products, combined with her enormously loyal customer base, we believe this very well-timed $3.5 million dollar hand sanitizer order, which we understand is an approximate four month supply for our customer, is just the beginning of a new and very exciting era for Dr Denese SkinScience", Morrison said.

"I have been fortunate during my 30+ years in the personal care space to have gained significant experience launching products and driving sales through a myriad of retail channels worldwide. Since the May 14 announcement that we were entering the multi-billion-dollar hand sanitizer market, I have taken the opportunity to discuss our new, premium grade hand sanitizer product with several large U.S. retail outlets. The reception we received was extremely positive. We are expecting substantial on-going growth in this exciting and innovative new product line", he added.

Pressure BioSciences develops and sells pressure-based instruments, consumables, and platform technology solutions to the biotechnology, biotherapeutics, cosmeceuticals, nutraceuticals, and food and beverage industries.

Contact the author at calum@proactiveinvestors.com

Follow him on Twitter @Cal_Proac

Quick facts: Pressure BioSciences, Inc.

Price: 2.15 USD

Market: OTCQB
Market Cap: $8.35 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Pressure BioSciences, Inc. named herein, including the promotion by the Company of Pressure BioSciences, Inc. in any Content on the Site, the...


Full interview: Pressure BioSciences PCT instrument deemed ‘essential’ by...

Pressure BioSciences Inc (OTCMKTS:PBIO) CEO Ric Schumacher tells Proactive the Massachusetts-based company’s patented pressure cycling technology (PCT) was featured in a presentation at the Annual Meeting of the Gynecologic Cancer Society in Brazil.  Schumacher explains the company’s PCT...

on 10/04/2019

3 min read